Serum immunoreactive leptin concentrations in patients with anorexia nervosa before and after partial weight recovery

Biochemical and Molecular Medicine

Volumn 60, Issue 2, 1997, Pages 116-120

  Casanueva, Felipe F ^a   Dieguez, Carlos ^b   Popovic, Vera ^d   Peino, Roberto ^a   Considine, Robert V ^c   Caro, Jose F ^c  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

LEPTIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; ANOREXIA NERVOSA; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOREACTIVITY; WEIGHT GAIN;

EID: 0031128355     PISSN: 10773150     EISSN: None     Source Type: Journal    
DOI: 10.1006/bmme.1996.2564     Document Type: Article

References (19)

1. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman J M. Positional cloning of the mouse obese gene and its human homologue. Nature. 372:1994;425-432.
2. Pelleymounter M A, Cullen M J, Baker M B, Hecht R, Winters D, Boone T, Collins F. Effects of the obese gene product on body weight regulation in ob/ob mice. Science. 269:1995;540-543.
3. Halaas J L, Gajiwala K S, Maffei M, Cohen S L, Chait B T, Rabinowitz D. Weight-reducing effects of the plasma proteins encoded by the obese gene. Science. 269:1995;543-546.
4. Campfield L A, Smith F J, Guisez Y, Devos R, Burn P. Recombinant mouse OB protein: Evidence for a peripheral signal linking adiposity and central neural networks. Science. 269:1995;546-549.
5. Considine R V, Considine E L, Williams C J, Nyce M R, Magosin S A, Bauer T L. Evidence against either a premature stop codon or the absence of obese gene mRNA in human obesity. J Clin Invest. 95:1995;2986-2988.
6. Lönnqvist F, Arner P, Nordfors L, Schalling M. Overexpression of the obese (ob) gene in adipose tissue of human obese subjects. Nat Med. 1:1995;950-953.
7. Hamilton B S, Paglia D, Kwan A YM, Deitel M. Increased obese mRNA expression in omental fat cells from massively obese humans. Nat Med. 1:1995;953-956.
8. Considine R V, Sinha M K, Heiman M L, Kriauciunas A, Stephens T W, Nyce M R. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med. 334:1995;292-295.
9. Russel G FM. Metabolic aspects of anorexia nervosa. Proc R Soc Med. 58:1965;811-814.
10. Kanis J A, Brown P, Fitzpatric K. Anorexia nervosa: A clinical psychiatric and laboratory study. Q J Med. 43:1974;321-338.
11. Crisp A R. Some aspects of evolution presentation and follow-up of anorexia nervosa. Proc R Soc Med. 58:1965;814-820.
12. Warren M P, Van der Wiele R L. Clinical and metabolic features of anorexia nervosa. Am J Obstet Gynecol. 117:1973;435-449.
13. Ann Intern Med. 116:1992;942-949.
14. Wilson G T, Walsh B T. Eating disorders in the DSM-IV. J Abnormal Psychol. 100:1991;362-365.
15. Stephens T W, Basinski M, Bristow P K, Bue-Valleskey J M, Burgett S G, Craft L. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature. 377:1995;530-532.
16. 125. Biochem J. 133:1973;529-539.
17. Jeanrenaud F R, Jeanrenaud B. Obesity, leptin and the brain. N Engl J Med. 334:1996;324-325.
18. Casanueva F F, Borras C G, Burguera B, Muruais C, Fernandez M, Devesa J. Steroids and neuroendocrine function in anorexia nervosa. J Steroid Biochem. 27:1987;635-640.
19. Casanueva F F, Borras C G, Burguera B, Lima L, Muruais C, Tresguerres J AF, Devesa J. Growth hormone and prolactin secretion after growth hormone-releasing hormone administration in anorexia nervosa patients, normal controls and tamoxifen pretreated volunteers. Clin Endocrinol. 27:1987;517-523.